Logo Prima Biomed

Welcome to the Newsroom

01 August 2015

Re: Results of 2015 Extraordinary General Meeting


Resolution 1:
“That, pursuant to and in accordance with Listing Rule 7.4 and for all other purposes, the Company ratifies the previous issue of 200,000,000 Warrants to the vendors of Immutep S.A. as part of the consideration to acquire 100% of the shares in Immutep S.A. in accordance with the terms of the Share Sale Agreement between Prima BioMed Ltd and Immutep S.A. executed and announced on 2nd October 2014, on the terms and  conditions set out in the Explanatory Notes.”